Kuhnil to complete health registration of Omacor for hyperlipidemia.
Omacor was originally developed by Pronova in Norway, approved very recently by the U. S. FDA as a prescription drug for the treatment of hyperlimpidemia an...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.